NAN FUNG GROUP HOLDINGS LTD Holdings

NAN FUNG GROUP HOLDINGS LTD is an investment fund managing more than 156.68M US dollars. The largest holdings include Karuna Therapeutics, Illumina and Harmony Biosciences Holdings. In Q3 2022 the fund bought assets of total value of 27.34M US dollars and sold assets of total value of 13.47M US dollars.

$156.67M

portfolio value

+11.41%

quarter

-25.22%

1 year

NAN FUNG GROUP HOLDINGS LTD portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2021	86814000	3854000
Q4 2021	42733000	520000
Q1 2022	3739000	10955000
Q2 2022	6787000	46730000
Q3 2022	27341000	13467000

NAN FUNG GROUP HOLDINGS LTD 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 34.69% Portfolio value: 54.35M Avg. open price: $126.51 Current price: $226.95 P/L: +79.39% Bought +7.07% shares Q3 2022	share	34.69%	54.35M	$126.51	$226.95	+79.39%	Bought +7.07% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 14.51% Portfolio value: 22.74M Avg. open price: N/A Current price: $213.86 P/L: N/A Sold -8.06% shares Q2 2022	share	14.51%	22.74M	N/A	$213.86	N/A	Sold -8.06% shares Q2 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 14.44% Portfolio value: 22.63M Avg. open price: N/A Current price: $60.91 P/L: N/A Sold -19.65% shares Q3 2022	share	14.44%	22.63M	N/A	$60.91	N/A	Sold -19.65% shares Q3 2022
Biotechnology Exscientia plc Portfolio share: 4.47% Portfolio value: 7.00M Avg. open price: $10.89 Current price: $5.51 P/L: -49.40% Bought +10.76% shares Q3 2022	share	4.47%	7.00M	$10.89	$5.51	-49.40%	Bought +10.76% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 4.11% Portfolio value: 6.44M Avg. open price: $157.19 Current price: $121.22 P/L: -22.88% Bought +3.87% shares Q1 2022	share	4.11%	6.44M	$157.19	$121.22	-22.88%	Bought +3.87% shares Q1 2022
Health Information Services SomaLogic, Inc. Portfolio share: 3.14% Portfolio value: 4.92M Avg. open price: N/A Current price: $2.7 P/L: N/A N/A Q3 2021	share	3.14%	4.92M	N/A	$2.7	N/A	N/A Q3 2021
Biotechnology Rani Therapeutics Holdings, Inc. Portfolio share: 3.02% Portfolio value: 4.72M Avg. open price: N/A Current price: $7.9 P/L: N/A N/A Q3 2021	share	3.02%	4.72M	N/A	$7.9	N/A	N/A Q3 2021
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 2.64% Portfolio value: 4.12M Avg. open price: N/A Current price: $38.83 P/L: N/A Sold -42.20% shares Q2 2022	share	2.64%	4.12M	N/A	$38.83	N/A	Sold -42.20% shares Q2 2022
Medical Devices Eargo, Inc. Portfolio share: 1.93% Portfolio value: 3.03M Avg. open price: N/A Current price: $0.61 P/L: N/A N/A Q2 2021	share	1.93%	3.03M	N/A	$0.61	N/A	N/A Q2 2021
Biotechnology Replimune Group, Inc. Portfolio share: 1.71% Portfolio value: 2.68M Avg. open price: $16.98 Current price: $19.95 P/L: +17.49% Bought +108.38% shares Q2 2022	share	1.71%	2.68M	$16.98	$19.95	+17.49%	Bought +108.38% shares Q2 2022
Biotechnology Incyte Corporation Portfolio share: 1.46% Portfolio value: 2.29M Avg. open price: N/A Current price: $84.08 P/L: N/A Sold -0.34% shares Q1 2022	share	1.46%	2.29M	N/A	$84.08	N/A	Sold -0.34% shares Q1 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 1.43% Portfolio value: 2.24M Avg. open price: N/A Current price: $22.77 P/L: N/A N/A Q3 2022	share	1.43%	2.24M	N/A	$22.77	N/A	N/A Q3 2022
Biotechnology Entrada Therapeutics, Inc. Portfolio share: 1.42% Portfolio value: 2.23M Avg. open price: N/A Current price: $17.96 P/L: N/A Sold -18.43% shares Q3 2022	share	1.42%	2.23M	N/A	$17.96	N/A	Sold -18.43% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.28% Portfolio value: 2.00M Avg. open price: N/A Current price: $21.89 P/L: N/A Sold -52.85% shares Q3 2022	share	1.28%	2.00M	N/A	$21.89	N/A	Sold -52.85% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 1.18% Portfolio value: 1.85M Avg. open price: N/A Current price: $51.99 P/L: N/A N/A Q1 2022	share	1.18%	1.85M	N/A	$51.99	N/A	N/A Q1 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 1.10% Portfolio value: 1.72M Avg. open price: N/A Current price: $1.4 P/L: N/A N/A Q2 2021	share	1.10%	1.72M	N/A	$1.4	N/A	N/A Q2 2021
Biotechnology BeiGene, Ltd. Portfolio share: 1.03% Portfolio value: 1.62M Avg. open price: $273.41 Current price: $188.71 P/L: -30.98% Bought +7.29% shares Q1 2022	share	1.03%	1.62M	$273.41	$188.71	-30.98%	Bought +7.29% shares Q1 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 0.73% Portfolio value: 1.14M Avg. open price: N/A Current price: $5.17 P/L: N/A N/A Q2 2021	share	0.73%	1.14M	N/A	$5.17	N/A	N/A Q2 2021
Biotechnology Galera Therapeutics, Inc. Portfolio share: 0.68% Portfolio value: 1.06M Avg. open price: N/A Current price: $1.67 P/L: N/A N/A Q2 2021	share	0.68%	1.06M	N/A	$1.67	N/A	N/A Q2 2021
Biotechnology Satsuma Pharmaceuticals, Inc. Portfolio share: 0.68% Portfolio value: 1.06M Avg. open price: $4.14 Current price: $0.89 P/L: -78.45% Bought +24.49% shares Q3 2022	share	0.68%	1.06M	$4.14	$0.89	-78.45%	Bought +24.49% shares Q3 2022
Biotechnology Exelixis, Inc. Portfolio share: 0.64% Portfolio value: 1.00M Avg. open price: N/A Current price: $17.22 P/L: N/A N/A Q2 2021	share	0.64%	1.00M	N/A	$17.22	N/A	N/A Q2 2021
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 0.54% Portfolio value: 841K Avg. open price: N/A Current price: $10.03 P/L: N/A Sold -15.67% shares Q1 2022	share	0.54%	841K	N/A	$10.03	N/A	Sold -15.67% shares Q1 2022
Biotechnology DBV Technologies S.A. Portfolio share: 0.42% Portfolio value: 657K Avg. open price: $5.46 Current price: $1.31 P/L: -76.01% Bought +29.93% shares Q3 2021	share	0.42%	657K	$5.46	$1.31	-76.01%	Bought +29.93% shares Q3 2021
Biotechnology 2seventy bio, Inc. Portfolio share: 0.37% Portfolio value: 586K Avg. open price: N/A Current price: $15.36 P/L: N/A N/A Q1 2022	share	0.37%	586K	N/A	$15.36	N/A	N/A Q1 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 0.33% Portfolio value: 518K Avg. open price: N/A Current price: $103.53 P/L: N/A Sold -18.03% shares Q1 2022	share	0.33%	518K	N/A	$103.53	N/A	Sold -18.03% shares Q1 2022
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 0.31% Portfolio value: 491K Avg. open price: N/A Current price: $15.24 P/L: N/A Sold -14.42% shares Q1 2022	share	0.31%	491K	N/A	$15.24	N/A	Sold -14.42% shares Q1 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.27% Portfolio value: 430K Avg. open price: N/A Current price: $119.41 P/L: N/A Sold -66.92% shares Q1 2022	share	0.27%	430K	N/A	$119.41	N/A	Sold -66.92% shares Q1 2022
Biotechnology ALX Oncology Holdings Inc. Portfolio share: 0.26% Portfolio value: 401K Avg. open price: $54.68 Current price: $11.92 P/L: -78.20% Bought +20.03% shares Q3 2021	share	0.26%	401K	$54.68	$11.92	-78.20%	Bought +20.03% shares Q3 2021
Biotechnology argenx SE Portfolio share: 0.25% Portfolio value: 392K Avg. open price: N/A Current price: $393.21 P/L: N/A Sold -1.77% shares Q1 2022	share	0.25%	392K	N/A	$393.21	N/A	Sold -1.77% shares Q1 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.16% Portfolio value: 251K Avg. open price: $2.17 Current price: $0.13 P/L: -93.96% Sold -0.01% shares Q3 2022	share	0.16%	251K	$2.17	$0.13	-93.96%	Sold -0.01% shares Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 0.13% Portfolio value: 209K Avg. open price: N/A Current price: $4.45 P/L: N/A N/A Q3 2022	share	0.13%	209K	N/A	$4.45	N/A	N/A Q3 2022
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 0.13% Portfolio value: 208K Avg. open price: N/A Current price: $39.62 P/L: N/A N/A Q2 2021	share	0.13%	208K	N/A	$39.62	N/A	N/A Q2 2021
Biotechnology FibroGen, Inc. Portfolio share: 0.12% Portfolio value: 192K Avg. open price: N/A Current price: $16.19 P/L: N/A N/A Q1 2022	share	0.12%	192K	N/A	$16.19	N/A	N/A Q1 2022
Biotechnology Affimed N.V. Portfolio share: 0.11% Portfolio value: 167K Avg. open price: N/A Current price: $2.12 P/L: N/A N/A Q1 2022	share	0.11%	167K	N/A	$2.12	N/A	N/A Q1 2022
Biotechnology Kodiak Sciences Inc. Portfolio share: 0.10% Portfolio value: 152K Avg. open price: $88.95 Current price: $7.26 P/L: -91.84% Bought +46.00% shares Q1 2022	share	0.10%	152K	$88.95	$7.26	-91.84%	Bought +46.00% shares Q1 2022
Biotechnology AbCellera Biologics Inc. Portfolio share: 0.08% Portfolio value: 124K Avg. open price: N/A Current price: $11.91 P/L: N/A Sold -5.00% shares Q1 2022	share	0.08%	124K	N/A	$11.91	N/A	Sold -5.00% shares Q1 2022
Biotechnology Synlogic, Inc. Portfolio share: 0.04% Portfolio value: 65K Avg. open price: N/A Current price: $0.74 P/L: N/A N/A Q2 2021	share	0.04%	65K	N/A	$0.74	N/A	N/A Q2 2021
Medical Devices Cerus Corporation Portfolio share: 0.03% Portfolio value: 51K Avg. open price: N/A Current price: $3.99 P/L: N/A N/A Q1 2022	share	0.03%	51K	N/A	$3.99	N/A	N/A Q1 2022
Diagnostics & Research Invitae Corporation Portfolio share: 0.02% Portfolio value: 28K Avg. open price: $28.43 Current price: $2.73 P/L: -90.40% Sold -92.73% shares Q2 2022	share	0.02%	28K	$28.43	$2.73	-90.40%	Sold -92.73% shares Q2 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $122.96 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$122.96	N/A	Sold -100.00% shares Q3 2022
Software—Application Snowflake Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $135.63 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$135.63	N/A	Sold -100.00% shares Q3 2022
Software—Infrastructure HashiCorp, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $26.11 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$26.11	N/A	Sold -100.00% shares Q3 2022
Biotechnology TCR2 Therapeutics Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.37 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.37	N/A	Sold -100.00% shares Q3 2022

Showing TOP 43 NAN FUNG GROUP HOLDINGS LTD's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of NAN FUNG GROUP HOLDINGS LTD?

The biggest position of the NAN FUNG GROUP HOLDINGS LTD is Karuna Therapeutics, Inc. (KRTX) with 34.69% portfolio share worth of 54.35M US dollars.

Top 5 NAN FUNG GROUP HOLDINGS LTD's holdings represent 72.23% of the portfolio:

Karuna Therapeutics, Inc. (KRTX) – 34.69%
Illumina, Inc. (ILMN) – 14.51%
Harmony Biosciences Holdings, Inc. (HRMY) – 14.44%
Exscientia plc (EXAI) – 4.47%
Seagen Inc. (SGEN) – 4.11%

Who is the portfolio manager of NAN FUNG GROUP HOLDINGS LTD?

The portfolio manager of the NAN FUNG GROUP HOLDINGS LTD is .

What is the total asset value of the NAN FUNG GROUP HOLDINGS LTD portfolio?

NAN FUNG GROUP HOLDINGS LTD total asset value (portfolio value) is 156.68M US dollars.

Who is ?

is the portfolio manager of the NAN FUNG GROUP HOLDINGS LTD.

What is (NAN FUNG GROUP HOLDINGS LTD) fund performance?

NAN FUNG GROUP HOLDINGS LTD's quarterly performance is +11.41%, annualy -25.22%.

What is the NAN FUNG GROUP HOLDINGS LTD CIK?

NAN FUNG GROUP HOLDINGS LTD's Central Index Key is 0001782539 .